Investec Bank Plc has filed a Form 8.5 public dealing disclosure relating to Advanced Medical Solutions Group Plc under Rule 8.5 of the Takeover Code.
The disclosure was made in Investec’s capacity as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity.
Investec Bank Plc holds a dual role in this matter, serving as both advisor and joint broker to Advanced Medical Solutions Group Plc.
The dealings covered in the disclosure were undertaken on 14th October 2026, with the filing itself dated 15th October 2026.
In terms of purchase activity, Investec reported buying 3,810 ordinary shares in Advanced Medical Solutions Group at a price of 282.25 pence per unit.
On the sales side, the firm disclosed the sale of 14,596 ordinary shares at a price of 282.5 pence per unit.
No cash-settled derivative transactions were reported as part of this disclosure filing, with those sections recorded as not applicable.
Similarly, no stock-settled derivative transactions, including options or other instruments, were disclosed in connection with the dealings.
Investec confirmed there are no indemnity or option arrangements, nor any agreements or understandings relating to relevant securities that could serve as an inducement to deal or refrain from dealing.
The bank also confirmed no agreements or understandings exist relating to voting rights under any option or to the future acquisition or disposal of relevant securities to which any derivative is referenced.
The disclosure contact listed in the filing is Priyali Bhattacharjee, reached at the telephone number provided within the official form submission.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be made to a recognised Regulatory Information Service in accordance with applicable rules.
